Search Results
Sarah Tasian, MD, on Advances, Challenges in Pediatric Hematologic Oncology at ASH 2022
Dr Sarah Tasian Discusses Challenges to Overcome When New Therapies Come to Market for Pediatric AML
Researcher Spotlight: Dr. Sarah Tasian
Where Discovery Leads: CAR-T with Sarah K. Tasian, MD
Clinical responses of pediatric patients with R/R acute leukemia treated with aza/ven
Pre-clinical activity of ziftomenib in pediatric KMT2A-rearranged ALL
Diagnostic strategies for Ph-like ALL
A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALL
MRD in pediatric ALL: clinical evidence, treatment decisions & outcomes
PMNET Forum 2024: Cellular Immunotherapies In Pediatric Care
Enhancing CAR-T Cell Therapies for Adult and Pediatric Cancers
ASPHO AML (Acute Myeloid Leukemia) #pediatric_oncology
